Tegretol Suspension
Product Images NDC 0078-0508

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tegretol (NDC 0078-0508). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tegretol 01

Tegretol 01
Tegretol-XR 200 is a medication used to treat seizures and nerve pain. It comes in extended-release tablets that should not be crushed or chewed. The recommended dosage and usage instructions should be followed as per the provided guide. The medication should be dispensed by a pharmacist. The text contains some gibberish characters and some parts of the text are not readable.*
FDA Label Image

Tegretol, Carbamazepine Structural Formula (Tegretol 02)

FDA Label Image

Tegretol 03

FDA Label Image

Principal Display Panelpackage Label – 200 mgrx Only Ndc 0078-0509-05tegretol® 200 mgcarbamazepine Usp100 Tabletspharmacist: Dispense With Medication Guide Attached Or Provided Separately. (Tegretol 04)

Principal Display Panelpackage Label – 200 mgrx Only		Ndc 0078-0509-05tegretol® 200 mgcarbamazepine Usp100 Tabletspharmacist: Dispense With Medication Guide Attached Or Provided Separately. (Tegretol 04)
Tegretol® 200mg is a medication containing carbamazepine USP. It should be noted that the text contains a mix of characters that make it difficult to understand.*
FDA Label Image

Principal Display Panelpackage Label – Xr 100 mgrx Only Ndc 0078-0510-05tegretol® Xr 100 mg(carbamazepine Extended-release Tablets)tegretol-xr Tablets Must Be Swallowedwhole And Never Crushed Or Chewed.100 Tabletspharmacist: Dispense With Medication Guide Attached Or Provided Separately. (Tegretol 05)

Principal Display Panelpackage Label – Xr 100 mgrx Only		Ndc 0078-0510-05tegretol® Xr 100 mg(carbamazepine Extended-release Tablets)tegretol-xr Tablets Must Be Swallowedwhole And Never Crushed Or Chewed.100 Tabletspharmacist: Dispense With Medication Guide Attached Or Provided Separately. (Tegretol 05)
This is a medication label for Tegretol-XR 100 extended-release tablets, containing carbamazepine. The label includes information on dosage, administration, and warnings. The medication should be swallowed whole and not crushed or chewed. It is intended for prescription use only and is manufactured by Novartis.*
FDA Label Image

Principal Display Panelpackage Label – Xr 200 mgrx Only Ndc 0078-0511-05tegretol® Xr 200 mg(carbamazepine Extended-release Tablets)tegretol-xr Tablets Must Be Swallowedwhole And Never Crushed Or Chewed.100 Tabletspharmacist: Dispense With Medication Guide Attached Or Provided Separately. (Tegretol 06)

Principal Display Panelpackage Label – Xr 200 mgrx Only		Ndc 0078-0511-05tegretol® Xr 200 mg(carbamazepine Extended-release Tablets)tegretol-xr Tablets Must Be Swallowedwhole And Never Crushed Or Chewed.100 Tabletspharmacist: Dispense With Medication Guide Attached Or Provided Separately. (Tegretol 06)
This is the label of Tegretol® suspension, a medication containing 100mg/5mL of carbamazepine USP used to treat seizures and nerve pain. It comes in a 450mL bottle and should be dispensed by a pharmacist. Dosage is indicated on the package. The medication should be stored below 85°F and out of reach of children. Manufactured by Pathoon Wity Inc. in Canada and distributed by Novartis Pharmaceuticals Corporation in East Hanover, New Jersey.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.